Business

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Building on the award-winning Allia platform for image guided therapies, the new Allia IGS Pulse was designed to improve workflow for the diagnosis and

articleGe Healthcare Technologies Inc.October 16, 20235/company/ge-healthcare-technologies-inc/news/ge-healthcare-receives-fda-clearance-of-allia-igs-pulse-the-next-generation-of-image-guided-systems-designed-for-cardiac-imaging-excellence
GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

About this update from Ge Healthcare Technologies Inc.

[{"type":"text","content":"\n\nBuilding on the award-winning Allia platform for image guided therapies, the new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology.\n\n\n\nAs part of its new image chain, the system features the first monopolar x-ray tube used for interventional procedures – providing exceptional image quality and optimized dose management regardless of patient size - including large and bariatric patients with a BMI of greater than 30.\n\n\n\n CHICAGO--(BUSINESS WIRE)--\nToday, GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231016347394/en/Building on the award-winning Allia platform for image guided therapies, GE HealthCare's new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology. (Photo: Business Wire)\nIn modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally.1 As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows.2 GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes.\n\n\nAccording to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to captu...

More updates from Ge Healthcare Technologies Inc.